Skip to main content

and
  1. Article

    Open Access

    Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis

    In migraine patients with a poor response to a calcitonin gene-related peptide monoclonal antibody against the receptor, switching to a calcitonin gene-related peptide monoclonal antibodies against the ligand ...

    Giorgio Lambru, Valeria Caponnetto, Bethany Hill, Susanna Ratti in Neurotherapeutics (2023)